Low dose of lenalidmide and PI3K/mTOR inhibitor trigger synergistic cytoxicity in activated B cell-like subtype of diffuse large B cell lymphoma.
about
Brain stereotactic biopsy flow cytometry for central nervous system lymphoma characterization: advantages and pitfalls.Synergistic effect of oridonin and a PI3K/mTOR inhibitor on the non-germinal center B cell-like subtype of diffuse large B cell lymphomaLenalidomide improvement of cisplatin antitumor efficacy on triple-negative breast cancer cells in vitro.
P2860
Low dose of lenalidmide and PI3K/mTOR inhibitor trigger synergistic cytoxicity in activated B cell-like subtype of diffuse large B cell lymphoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Low dose of lenalidmide and PI ...... diffuse large B cell lymphoma.
@ast
Low dose of lenalidmide and PI ...... diffuse large B cell lymphoma.
@en
type
label
Low dose of lenalidmide and PI ...... diffuse large B cell lymphoma.
@ast
Low dose of lenalidmide and PI ...... diffuse large B cell lymphoma.
@en
prefLabel
Low dose of lenalidmide and PI ...... diffuse large B cell lymphoma.
@ast
Low dose of lenalidmide and PI ...... diffuse large B cell lymphoma.
@en
P2093
P2860
P1476
Low dose of lenalidmide and PI ...... diffuse large B cell lymphoma.
@en
P2093
Wenfang Wang
Xiaoyang Li
Yuan Ouyang
P2860
P2888
P356
10.1186/S13046-016-0327-X
P577
2016-03-24T00:00:00Z
P6179
1006645523